Being born before 37 weeks' gestation, or preterm birth, is a leading cause of early
childhood death and life-long disability. Antenatal steroids (ANS) are recommended for …

Antenatal steroids (ANS) are among the most important and widely utilized interventions to
improve outcomes for preterm infants. A significant body of evidence demonstrates improved …

This chapter on therapeutic drift with antenatal steroids will make the case that this pilar of
treatment to improve the outcomes of preterm infants, despite multiple Randomized Control …

Objective The timing of antenatal steroids (ANS) on short-and long-term effects on newborn
infants was evaluated. Study Design This study was conducted at the University of …

Abstract The Antenatal Late Preterm Steroids (ALPS) trial was designed to address
respiratory morbidity common in infants born late preterm. The study was published in April …

Antenatal steroid therapy is standard care for women at imminent risk of preterm delivery.
When deliveries occur within 7 days of treatment, antenatal steroid therapy reduces the risk …

There is no controversy about the core conclusion that women at risk of preterm delivery
before 32 to 34 weeks' gestational age should be treated with antenatal steroids. This …

Antenatal steroid therapy is increasingly central to the obstetrical management of women at
imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks' …

Background In 2016, guidance statements were issued by the Society for Maternal-Fetal
Medicine and the American Congress of Obstetricians and Gynecologists about extending …

Objective: Antenatal steroid use has been associated with reduction in the risk of neonatal
mortality in meta-analyses of clinical trials. In 2007, a revised US birth certificate offered …